Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in a patient with refractory Behçet's disease uveitis and concomitant bladder papillary carcinoma

I Orlando; A Vitale; Donato Rigante; G Lopalco; C Fabiani; L. Cantarini

doi:10.1111/imj.13538

Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in a patient with refractory Behçet's disease uveitis and concomitant bladder papillary carcinoma

I Orlando
, A Vitale
, Donato Rigante
, G Lopalco
, C Fabiani
, L. Cantarini

Risultato della ricerca: Contributo in rivista › Articolo

6 Citazioni (Scopus)

Abstract

The authors describe a patient with Behçet's disease treated with anakinra and canakinumab after bladder papillary cancer excision. The same patient had been previously proven to be unresponsive to standard therapy, including TNF-α inhibitors.

Lingua originale	Inglese
pagine (da-a)	1-5
Numero di pagine	5
Rivista	Internal Medicine Journal
Volume	2017
Numero di pubblicazione	47(9)
DOI	https://doi.org/10.1111/imj.13538
Stato di pubblicazione	Pubblicato - 2017

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

All Science Journal Classification (ASJC) codes

Medicina Interna

Keywords

Behçet's disease

Accesso al documento

10.1111/imj.13538

Altri file e collegamenti

Cita questo

@article{9406a8712a3447c2a330161c8b179ed6,

title = "Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in a patient with refractory Beh{\c c}et's disease uveitis and concomitant bladder papillary carcinoma",

abstract = "The authors describe a patient with Beh{\c c}et's disease treated with anakinra and canakinumab after bladder papillary cancer excision. The same patient had been previously proven to be unresponsive to standard therapy, including TNF-α inhibitors.",

keywords = "Beh{\c c}et's disease, Beh{\c c}et's disease",

author = "I Orlando and A Vitale and Donato Rigante and G Lopalco and C Fabiani and L. Cantarini",

year = "2017",

doi = "10.1111/imj.13538",

language = "English",

volume = "2017",

pages = "1--5",

journal = "Internal Medicine Journal",

issn = "1445-5994",

publisher = "John Wiley and Sons Inc.",

number = "47(9)",

}

TY - JOUR

T1 - Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in a patient with refractory Behçet's disease uveitis and concomitant bladder papillary carcinoma

AU - Orlando, I

AU - Vitale, A

AU - Rigante, Donato

AU - Lopalco, G

AU - Fabiani, C

AU - Cantarini, L.

PY - 2017

Y1 - 2017

N2 - The authors describe a patient with Behçet's disease treated with anakinra and canakinumab after bladder papillary cancer excision. The same patient had been previously proven to be unresponsive to standard therapy, including TNF-α inhibitors.

AB - The authors describe a patient with Behçet's disease treated with anakinra and canakinumab after bladder papillary cancer excision. The same patient had been previously proven to be unresponsive to standard therapy, including TNF-α inhibitors.

KW - Behçet's disease

UR - https://publicatt.unicatt.it/handle/10807/105214

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85029032165&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85029032165&origin=inward

U2 - 10.1111/imj.13538

DO - 10.1111/imj.13538

M3 - Article

SN - 1445-5994

VL - 2017

SP - 1

EP - 5

JO - Internal Medicine Journal

JF - Internal Medicine Journal

IS - 47(9)

ER -

Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in a patient with refractory Behçet's disease uveitis and concomitant bladder papillary carcinoma

Abstract

OSS delle Nazioni Unite

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo